Psychedelic Business Spotlight: September 10, 2021
This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.
dmt
Michigan Senators Propose Bill Legalizing Plant-Based Psychedelics
“Decriminalization of entheogenic substances makes sense,” says Senator Jeff Irwin. “Let’s stop wasting time and money making more victims of the War on Drugs.”
Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%
The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
Top 5 ‘Joe Rogan Experience’ Episodes About Psychedelics
Yes, Joe Rogan is a subversive. But he’s a subversive who knows a thing or two about psychedelics.
Mindset Pharma’s DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge
“The data suggests that we have a new drug that may be at least as effective, if not more effective, than 5-MeO-DMT and, more importantly, it looks like it is much safer,” says Mindset Pharma CEO James Lanthier.
Psychedelic Business Spotlight: August 20, 2021
This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing.
5 Ways Psychedelics Can Help Humanity with Medicinal Benefits You Never Imagined
DMT treating eye disease? Psilocybin reducing obesity? The benefits of psychedelics could be truly far out as research continues to find novel applications.
Akome Biotech Patents Psychedelic Drug Formulation to Treat Parkinson’s Disease
There is currently no known cure for the disease affecting 10 million people worldwide, but this psychedelics company thinks it has found a “viable candidate” using DMT.
Do Psychedelics Hold the Key to Explaining Near-Death Experiences?
New research into psychedelics shows it may help scientists better understand the phenomenon known as near-death experiences.
Algernon to Become the First Company in the World to Study DMT for Stroke Patients
Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.
End of content
End of content